Kevin Lee Freeman - Feb 20, 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Commercial Officer
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Feb 20, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/24/2025, 08:49 PM
Previous filing: Dec 3, 2024
Next filing: Mar 4, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Award	$0	+140K	+59.08%	$0.00	377K	Feb 20, 2025	Direct	F1
transaction	HCAT	Common Stock	Award	$0	+18.3K	+4.84%	$0.00	395K	Feb 20, 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.
F2	Represents an award of 18,262 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.

Content

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.

Represents an award of 18,262 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.